Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome
Fragile X syndrome (FXS) is the most common inherited form of intellectual disability and autism. FXS is also accompanied by attention problems, hyperactivity, anxiety, aggression, poor sleep, repetitive behaviors, and self-injury. Recent work supports the role of γ-aminobutyric-acid (GABA), the pri...
Main Authors: | Patricia Cogram, Robert M. J. Deacon, Jennifer L. Warner-Schmidt, Melanie J. von Schimmelmann, Brett S. Abrahams, Matthew J. During |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Behavioral Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnbeh.2019.00141/full |
Similar Items
-
Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study
by: Dejan B. Budimirovic, et al.
Published: (2021-10-01) -
Altered Gut Microbiota in a Fragile X Syndrome Mouse Model
by: Francisco Altimiras, et al.
Published: (2021-05-01) -
Inositol and protein kinase C in the prevention of neural tube defects
by: Cogram, Patricia
Published: (2008) -
Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice
by: Patricia Cogram, et al.
Published: (2020-10-01) -
Editorial: Human and Animal Models for Translational Research on Neurodegeneration: Challenges and Opportunities From South America
by: Agustín Ibáñez, et al.
Published: (2018-04-01)